We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$7.65B
AUM Growth
-$2.07B
Cap. Flow
-$890M
Cap. Flow %
-11.64%
Top 10 Hldgs %
69.25%
Holding
109
New
20
Increased
5
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ONON icon
On Holding
ONON
+$561M
2
LEGN icon
Legend Biotech
LEGN
+$433M
3
CTKB icon
Cytek Biosciences
CTKB
+$206M
4
SE icon
Sea Limited
SE
+$101M
5
ERAS icon
Erasca
ERAS
+$97.4M

Top Sells

Rank Stock Value
1
ESGR
Enstar Group
ESGR
+$418M
2
PDD icon
Pinduoduo
PDD
+$398M
3
ZM icon
Zoom
ZM
+$398M
4
ABNB icon
Airbnb
ABNB
+$300M
5
UBER icon
Uber
UBER
+$188M

Sector Composition

Rank Sector Weight
1 Healthcare 57.57%
2 Consumer Discretionary 24.98%
3 Technology 6.63%
4 Communication Services 6.51%
5 Consumer Staples 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.9B
$1.99B 25.98%
5,472,259
LEGN icon
2
Legend Biotech
LEGN
$3.68B
$559M 7.31%
11,054,925
+10,404,925
+1,601% +$433M
NBP
3
NovaBridge Biosciences American Depositary Shares
NBP
$195M
$521M 6.81%
7,182,850
+566,680
+9% +$41M
ONON icon
4
On Holding
ONON
$12.4B
$481M 6.29%
+15,973,750
New +$561M
JD icon
5
JD.com
JD
$43.3B
$344M 4.5%
4,767,307
+1,084,000
+29% +$79.9M
CRM icon
6
Salesforce
CRM
$151B
$340M 4.45%
1,254,176
+117,700
+10% +$29.9M
IQ icon
7
iQIYI
IQ
$1.2B
$310M 4.06%
38,648,477
PDD icon
8
Pinduoduo
PDD
$124B
$255M 3.33%
2,808,000
-4,094,129
-59% -$398M
BBIO icon
9
BridgeBio Pharma
BBIO
$16.6B
$251M 3.29%
5,362,014
DASH icon
10
DoorDash
DASH
$85.6B
$246M 3.22%
1,196,300
CTKB icon
11
Cytek Biosciences
CTKB
$573M
$187M 2.45%
+8,757,030
New +$206M
BEAM icon
12
Beam Therapeutics
BEAM
$2.66B
$126M 1.65%
1,448,161
-397,592
-22% -$39.9M
MDLZ icon
13
Mondelez International
MDLZ
$84B
$108M 1.42%
1,862,164
BABA icon
14
Alibaba
BABA
$275B
$106M 1.38%
713,400
SE icon
15
Sea Limited
SE
$66.5B
$105M 1.38%
+330,000
New +$101M
ERAS icon
16
Erasca
ERAS
$6.14B
$100M 1.31%
+4,722,221
New +$97.4M
VIPS icon
17
Vipshop
VIPS
$7.19B
$99.9M 1.31%
8,963,752
GOSS icon
18
Gossamer Bio
GOSS
$91.2M
$93.3M 1.22%
7,420,974
BEKE icon
19
KE Holdings
BEKE
$17.7B
$91.5M 1.2%
5,012,100
PLTK icon
20
Playtika
PLTK
$1.53B
$90.6M 1.19%
3,280,699
ILMN icon
21
Illumina
ILMN
$29.4B
$68M 0.89%
+172,307
New +$79.2M
CPNG icon
22
Coupang
CPNG
$27B
$60.7M 0.79%
+2,180,272
New +$75.4M
TNGX icon
23
Tango Therapeutics
TNGX
$4.28B
$56.6M 0.74%
+4,373,982
New +$52.4M
AMG icon
24
Affiliated Managers Group
AMG
$9.64B
$50.6M 0.66%
335,073
UBER icon
25
Uber
UBER
$143B
$49.9M 0.65%
1,114,000
-4,306,202
-79% -$188M

Similar funds

HHLR Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, HHLR Advisors held 109 positions worth $7.65B, down 21% from $9.71B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HHLR Advisors withdrew a net $890M in Q3 2021, closing 24 positions and reducing 15 holdings. Its most notable exit was Enstar Group, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in On Holding worth $481M.

  • HHLR Advisors's largest Q3 2021 buy was On Holding: 15,973,750 shares worth $481M.
  • HHLR Advisors added most to Legend Biotech in Q3 2021, an estimated $433M increase.
  • HHLR Advisors's biggest Q3 2021 reduction was Pinduoduo, cutting an estimated $398M.
  • HHLR Advisors fully exited Enstar Group in Q3 2021, selling an estimated $418M.
  • HHLR Advisors's ten largest holdings make up 69% of its $7.65B portfolio in Q3 2021.
  • HHLR Advisors opened 20 new positions and closed 24 in Q3 2021.
  • HHLR Advisors's portfolio value fell 21% quarter-over-quarter to $7.65B.

Based on HHLR Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.